Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Progenics Pharmaceuticals (NQ: PGNX )

4.100 USD UNCHANGED
Last Price Updated: 7:59 PM EDT, Jun 19, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 4.100
Bid (Size) 4.240 (41)
Ask (Size) 4.350 (3)
Prev. Close 4.100
Today's Range 4.100 - 4.100
52wk Range 1.890 - 5.370
Shares Outstanding 73,718,684
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Independent Bank Group Set to Join S&P SmallCap 600
Independent Bank Group Inc. (NASD: IBTX) will replace Progenics Pharmaceuticals Inc. (NASD: PGNX) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, June 22. S&P Small-Cap 600... 
From PR Newswire
Progenics Stockholders Approve Merger with Lantheus
From GlobeNewswire News Releases

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
-11.64%
-11.64%

More News

Read More
SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.
From PR Newswire
Lantheus Completes Merger with Progenics
From Business Wire News Releases
Progenics to Present Results from the Phase 3 CONDOR Trial of PyL™ (18F-DCFPyL) in Prostate Cancer at the American Society of Clinical Oncology 2020 Virtual Scientific Program
From GlobeNewswire News Releases
Progenics Class Action: Halper Sadeh LLP Announces Filing Of Shareholder Class Action Lawsuit Against Progenics Pharmaceuticals, Inc.; Investors Are Encouraged To Contact The Firm
From PR Newswire
Progenics Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update
From GlobeNewswire News Releases
Lantheus Stockholders Approve Share Issuance For Merger with Progenics
From Business Wire News Releases
Progenics Pharmaceuticals Sets First Quarter 2020 Financial Results and Business Update Call for May 7
From GlobeNewswire News Releases
ADDING MULTIMEDIA Velan Capital Agrees to Support Merger of Lantheus and Progenics
From Business Wire News Releases
2 Top Cancer Treatment Stocks To Watch In July
Tags PGNX ALXN VIR
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.